On these two fronts - a note informs - 'The Metabolic Frontier 2026', the first Italian symposium dedicated to the impact of therapies with GLP-1 receptor agonists on health, nutrition, and health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results